Next Article in Journal
Fucoidan Isolated from Saccharina japonica Inhibits LPS-Induced Inflammation in Macrophages via Blocking NF-κB, MAPK and JAK-STAT Pathways
Next Article in Special Issue
Bioactive Ascochlorin Analogues from the Marine-Derived Fungus Stilbella fimetaria
Previous Article in Journal / Special Issue
In Vitro and In Vivo Assessment of the Efficacy of Bromoageliferin, an Alkaloid Isolated from the Sponge Agelas dilatata, against Pseudomonas aeruginosa
Article

Bioactivity of Spongian Diterpenoid Scaffolds from the Antarctic Sponge Dendrilla antarctica

1
Department of Chemistry, University of South Florida, 4202 E. Fowler Avenue, CHE205, Tampa, FL 33620, USA
2
Department of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, 4202 E. Fowler Avenue, ISA2015, Tampa, FL 33620, USA
3
USF Center for Global Health and Infectious Diseases Research, University of South Florida, 3010 USF Banyan Circle, IDRB 304, Tampa, FL 33612, USA
4
Department of Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this paper.
Mar. Drugs 2020, 18(6), 327; https://doi.org/10.3390/md18060327
Received: 13 May 2020 / Revised: 10 June 2020 / Accepted: 12 June 2020 / Published: 23 June 2020
(This article belongs to the Special Issue Structure–Activity Relationship of Marine Bioactive Compounds)
The Antarctic sponge Dendrilla antarctica is rich in defensive terpenoids with promising antimicrobial potential. Investigation of this demosponge has resulted in the generation of a small chemical library containing diterpenoid secondary metabolites with bioactivity in an infectious disease screening campaign focused on Leishmania donovani, Plasmodium falciparum, and methicillin-resistant Staphylococcus aureus (MRSA) biofilm. In total, eleven natural products were isolated, including three new compounds designated dendrillins B–D (1012). Chemical modification of abundant natural products led to three semisynthetic derivatives (1315), which were also screened. Several compounds showed potency against the leishmaniasis parasite, with the natural products tetrahydroaplysulphurin-1 (4) and dendrillin B (10), as well as the semisynthetic triol 15, displaying single-digit micromolar activity and low mammalian cytotoxicity. Triol 15 displayed the best profile against the liver-stage malaria parasites, while membranolide (5) and dendrillin C (11) were strong hits against MRSA biofilm cultures. View Full-Text
Keywords: diterpenoids; dendrillins; malaria; leishmaniasis; MRSA biofilm diterpenoids; dendrillins; malaria; leishmaniasis; MRSA biofilm
Show Figures

Figure 1

MDPI and ACS Style

Bory, A.; Shilling, A.J.; Allen, J.; Azhari, A.; Roth, A.; Shaw, L.N.; Kyle, D.E.; Adams, J.H.; Amsler, C.D.; McClintock, J.B.; Baker, B.J. Bioactivity of Spongian Diterpenoid Scaffolds from the Antarctic Sponge Dendrilla antarctica. Mar. Drugs 2020, 18, 327. https://doi.org/10.3390/md18060327

AMA Style

Bory A, Shilling AJ, Allen J, Azhari A, Roth A, Shaw LN, Kyle DE, Adams JH, Amsler CD, McClintock JB, Baker BJ. Bioactivity of Spongian Diterpenoid Scaffolds from the Antarctic Sponge Dendrilla antarctica. Marine Drugs. 2020; 18(6):327. https://doi.org/10.3390/md18060327

Chicago/Turabian Style

Bory, Alexandre, Andrew J. Shilling, Jessie Allen, Ala Azhari, Alison Roth, Lindsey N. Shaw, Dennis E. Kyle, John H. Adams, Charles D. Amsler, James B. McClintock, and Bill J. Baker. 2020. "Bioactivity of Spongian Diterpenoid Scaffolds from the Antarctic Sponge Dendrilla antarctica" Marine Drugs 18, no. 6: 327. https://doi.org/10.3390/md18060327

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop